Gallafent, Alison competitive analysis

Explore patent oppositions filed by Gallafent, Alison against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
Sustained Analgesia Achieved With Transdermal Delivery Of BuprenorphineEURO CELTIQUEJan 24, 2014

Latest PTAB cases involving Gallafent, Alison

Discover the latest PTAB cases involving Gallafent, Alison, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Gallafent, Alison with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GALLAFENT, ALISON1 - - -
EURO CELTIQUE - 44 - -
MUNDIPHARMA - 25 - -
NAPP PHARMACEUTICAL - 25 - -